In a study involving 30 patients with type 2 diabetes mellitus, intravenous administration of alpha-lipoic acid (ALA) for 3 weeks was found to reduce concentrations of asymmetric dimethylarginine (mean change: -0.05 micromol/L) – which when elevated, is associated with cardiovascular events in patients with type 2 diabetes. No such change was found when placebo was administered (0.01 micromol/L). ALA results did not affect levels of symmetric dimethylarginine and L-arginine. The authors conclude, "Long-term studies need to demonstrate if ALA may cause cardiovascular risk reduction."

How Stem Cell Therapy Rejuvenates Hair Follicles and Promotes Growth
Hair thinning and hair loss often happen when follicles are no longer functioning at their best. Some follicles may slow
